Anton, I.C.; Mititelu-Tartau, L.; Popa, E.G.; Poroch, M.; Poroch, V.; Pintilei, D.R.; Botnariu, G.E.
Clinical Parameters Affecting the Therapeutic Efficacy of SGLT-2—Comparative Effectiveness and Safety of Dapagliflozin and Empagliflozin in Patients with Type 2 Diabetes. Healthcare 2022, 10, 1153.
https://doi.org/10.3390/healthcare10071153
AMA Style
Anton IC, Mititelu-Tartau L, Popa EG, Poroch M, Poroch V, Pintilei DR, Botnariu GE.
Clinical Parameters Affecting the Therapeutic Efficacy of SGLT-2—Comparative Effectiveness and Safety of Dapagliflozin and Empagliflozin in Patients with Type 2 Diabetes. Healthcare. 2022; 10(7):1153.
https://doi.org/10.3390/healthcare10071153
Chicago/Turabian Style
Anton, Irina Claudia, Liliana Mititelu-Tartau, Eliza Gratiela Popa, Mihaela Poroch, Vladimir Poroch, Delia Reurean Pintilei, and Gina Eosefina Botnariu.
2022. "Clinical Parameters Affecting the Therapeutic Efficacy of SGLT-2—Comparative Effectiveness and Safety of Dapagliflozin and Empagliflozin in Patients with Type 2 Diabetes" Healthcare 10, no. 7: 1153.
https://doi.org/10.3390/healthcare10071153
APA Style
Anton, I. C., Mititelu-Tartau, L., Popa, E. G., Poroch, M., Poroch, V., Pintilei, D. R., & Botnariu, G. E.
(2022). Clinical Parameters Affecting the Therapeutic Efficacy of SGLT-2—Comparative Effectiveness and Safety of Dapagliflozin and Empagliflozin in Patients with Type 2 Diabetes. Healthcare, 10(7), 1153.
https://doi.org/10.3390/healthcare10071153
